SCHEMBL24375459

SCHEMBL24375459

Cc1cc(=O)[nH]nc1Oc1c(Cl)cc(N)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 1/20 0.34
CYP3A4 P08684 2/20 0.33
RARG P13631 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
THRA P10827 5/20 0.32
THRB P10828 5/20 0.32
CYP2C9 P11712 1/20 0.32
UGT1A1 P22309 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
SLCO1B1 Q9Y6L6 1/20 0.32
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
JAK1 P23458 1/20 0.30
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15577638 0.82 THRB (0.42) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL29620357 0.81 ALDH1A1 (0.41) ALDH1A1MAPTCYP2C9GRIN2DGRIN3B
SCHEMBL24375457 0.79 THRB (0.36) RARGMAPTTHRATHRBCYP2C9
SCHEMBL23260177 0.79 JAK1 (0.34) RARGMAPTHPGDTHRATHRB
SCHEMBL23259890 0.74 THRB (0.40) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL26026993 0.74 RARG (0.44) TNKS2RARGTHRATHRBCYP2C9
SCHEMBL23259875 0.74 THRB (0.39) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL26027125 0.73 RARG (0.39) RARGALDH1A1KDM4EMAPTTHRA
SCHEMBL24375458 0.73 THRB (0.46) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL22077247 0.73 PARP1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240051925-A1 METHODS FOR PREPARING PYRIDAZINONE DERIVATIVES LSI FINANCING LLC, AS ADMINISTRATIVE AGENT 2024-02-15 US disclosed
EP-4232436-A1 PROCESS FOR THE PREPARATION OF 6-(4-NITRO-PHENOXY)-2H-PYRIDAZIN-3-ONE AND 6-(4-AMINO-PHENOXY)-2H-PYRIDAZIN-3-ONE DERIVATIVES AS INTERMEDIATES OF THYROID HORMONE ANALOGUES Madrigal Pharmaceuticals, Inc. (US) 2023-08-30 EP disclosed
CN-116406356-A Process for the preparation of 6- (4-nitro-phenoxy) -2H-pyridazin-3-one and 6- (4-amino-phenoxy) -2H-pyridazin-3-one derivatives as intermediates for thyroid hormone analogues 马德里加尔制药公司 2023-07-07 CN disclosed
WO-2022087141-A1 PROCESS FOR THE PREPARATION OF 6-(4-NITRO-PHENOXY)-2H-PYRIDAZIN-3-ONE AND 6-(4-AMINO-PHENOXY)-2H-PYRIDAZIN-3-ONE DERIVATIVES AS INTERMEDIATES OF THYROID HORMONE ANALOGUES MADRIGAL PHARMACEUTICALS, INC. (US) 2022-04-28 WO disclosed
WO-2022087141-A1 PROCESS FOR THE PREPARATION OF 6-(4-NITRO-PHENOXY)-2H-PYRIDAZIN-3-ONE AND 6-(4-AMINO-PHENOXY)-2H-PYRIDAZIN-3-ONE DERIVATIVES AS INTERMEDIATES OF THYROID HORMONE ANALOGUES MADRIGAL PHARMACEUTICALS, INC. (US) 2022-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240051925-A1 METHODS FOR PREPARING PYRIDAZINONE DERIVATIVES CYP7A1, LIPC, CYP11B2 TNKS2 3426/4885CYP3A4 83/4885RARG 2094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.